Announcements Trials

Browse Landscape

Phase

Phase NA 1 Phase 3 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 8 Lymphoma 7 Lymphoma, Follicular 6 Leukemia, Biphenotypic, Acute 6 Leukemia 6 Lymphoma, Non-Hodgkin 4 Lymphoma, Large B-Cell, Diffuse 4 Lymphoma, Large-Cell, Immunoblastic 3 Leukemia, Myeloid, Acute 3 Burkitt Lymphoma 3 Prostatic Neoplasms 2 Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 2 Neoplasms 2 Multiple Myeloma 2 Lymphohistiocytosis, Hemophagocytic 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Graft vs Host Disease 2 Epstein-Barr Virus Infections 2 Recurrence 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Pneumonia, Pneumocystis 1 Pneumonia 1 Pain 1 Neurotoxicity Syndromes 1 Neuroma, Acoustic 1 Neoplasms, Plasma Cell 1 Neoplasm Metastasis 1 Lymphoma, Large-Cell, Anaplastic 1 Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8 1 Leukemia, Myeloid, Chronic-Phase 1

Interventions

Nebulizers and Vaporizers 1 Methylprednisolone 1 Lidocaine 1 Etanercept 1 Adrenal Cortex Hormones 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Pneumonia × Methylprednisolone × Clear all

NCT00421174 2021-11-01

BMTCTN0403

National Heart, Lung, and Blood Institute (NHLBI)

Phase 3 Completed

37 enrolled 20 charts

Pneumonia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡